Imunon, Inc. Available-for-sale Securities, Gross Realized Gain (Loss)
Imunon, Inc. (IMNN) reported Available-for-sale Securities, Gross Realized Gain (Loss) of -$1.78 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedGainLossNet · last filed 2021-08-12
- Imunon, Inc. available-for-sale securities, gross realized gain (loss) for the quarter ending 2021-06-30 was -$1.78K, a 162.30% decline year-over-year.
- Imunon, Inc. available-for-sale securities, gross realized gain (loss) for the quarter ending 2020-12-31 was $0.00.
- Imunon, Inc. available-for-sale securities, gross realized gain (loss) for the quarter ending 2020-09-30 was $7.26K, a 87.50% decline year-over-year.
- Imunon, Inc. available-for-sale securities, gross realized gain (loss) for the quarter ending 2020-06-30 was $2.87K, a 195.67% increase year-over-year.
- Imunon, Inc. available-for-sale securities, gross realized gain (loss) for fiscal 2020 was $53.35K, a 7.84% decline from fiscal 2019.
- Imunon, Inc. available-for-sale securities, gross realized gain (loss) for fiscal 2019 was $57.90K.
- Imunon, Inc. available-for-sale securities, gross realized gain (loss) for fiscal 2018 was -$10.16K.
- Imunon, Inc. available-for-sale securities, gross realized gain (loss) for fiscal 2016 was -$532.00, a 301.52% decline from fiscal 2015.
| Period end | Available-for-sale Securities, Gross Realized Gain (Loss) 3 month | Available-for-sale Securities, Gross Realized Gain (Loss) 6 month | Available-for-sale Securities, Gross Realized Gain (Loss) 9 month | Available-for-sale Securities, Gross Realized Gain (Loss) 12 month | Available-for-sale Securities, Gross Realized Gain (Loss) 12 month as first filed |
|---|---|---|---|---|---|
| 2021-06-30 | -$1.78K 10-Q · filed 2021-08-12 | -$1.78K 10-Q · filed 2021-08-12 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $7.26K derived: sum of 2 quarters · filed 2021-03-19 | $10.12K derived: sum of 3 quarters · filed 2021-08-12 | $53.35K 10-K · filed 2021-03-19 | |
| 2020-09-30 | $7.26K 10-Q · filed 2020-11-16 | $10.12K derived: sum of 2 quarters · filed 2021-08-12 | $53.35K 10-Q · filed 2020-11-16 | $42.83K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-06-30 | $2.87K 10-Q · filed 2021-08-12 | $46.10K 10-Q · filed 2021-08-12 | $35.57K derived: sum of 3 quarters · filed 2021-08-12 | $93.64K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $43.23K 10-Q · filed 2021-05-14 | $32.71K derived: sum of 2 quarters · filed 2021-05-14 | $90.78K derived: sum of 3 quarters · filed 2021-05-14 | $91.75K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | -$10.52K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $47.55K derived: sum of 2 quarters · filed 2021-03-19 | $48.51K derived: sum of 3 quarters · filed 2021-03-19 | $57.90K 10-K · filed 2021-03-19 | |
| 2019-09-30 | $58.07K 10-Q · filed 2020-11-16 | $59.04K derived: sum of 2 quarters · filed 2020-11-16 | $68.42K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $969.00 10-Q · filed 2020-08-14 | $10.35K 10-Q · filed 2020-08-14 | |||
| 2019-03-31 | $9.38K 10-Q · filed 2020-05-15 | ||||
| 2018-12-31 | -$10.16K 10-K · filed 2020-03-25 | ||||
| 2016-12-31 | $3.33K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-27 | $3.33K derived: sum of 2 quarters · filed 2018-03-27 | $3.33K derived: sum of 3 quarters · filed 2018-03-27 | -$532.00 10-K · filed 2018-03-27 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | -$3.86K 10-Q · filed 2016-11-10 | -$3.49K derived: sum of 4 quarters · filed 2017-05-12 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$3.86K 10-Q · filed 2016-08-15 | -$3.49K derived: sum of 3 quarters · filed 2017-05-12 | -$3.38K derived: sum of 4 quarters · filed 2017-05-12 | |
| 2016-03-31 | -$3.86K 10-Q · filed 2017-05-12 | -$3.49K derived: sum of 2 quarters · filed 2017-05-12 | -$3.38K derived: sum of 3 quarters · filed 2017-05-12 | -$3.72K derived: sum of 4 quarters · filed 2017-05-12 | |
| 2015-12-31 | $368.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | $474.00 derived: sum of 2 quarters · filed 2017-03-24 | $135.00 derived: sum of 3 quarters · filed 2017-03-24 | $264.00 10-K · filed 2017-03-24 | |
| 2015-09-30 | $106.00 10-Q · filed 2016-11-10 | -$233.00 derived: sum of 2 quarters · filed 2016-11-10 | -$104.00 10-Q · filed 2016-11-10 | -$25.05K derived: sum of 4 quarters · filed 2016-11-10 | |
| 2015-06-30 | -$339.00 10-Q · filed 2016-08-15 | -$210.00 10-Q · filed 2016-08-15 | -$25.16K derived: sum of 3 quarters · filed 2016-08-15 | -$24.94K derived: sum of 4 quarters · filed 2016-08-15 | |
| 2015-03-31 | $129.00 10-Q · filed 2016-05-16 | -$24.82K derived: sum of 2 quarters · filed 2016-05-16 | -$24.60K derived: sum of 3 quarters · filed 2016-05-16 | -$27.68K derived: sum of 4 quarters · filed 2016-05-16 | |
| 2014-12-31 | -$24.95K derived: 10-K 6 month − 10-Q 3 month · filed 2015-03-12 | -$24.73K 10-K · filed 2015-03-12 | -$27.81K derived: sum of 3 quarters · filed 2015-11-05 | -$24.73K 10-K · filed 2016-03-30 | |
| 2014-09-30 | $218.00 10-Q · filed 2015-11-05 | -$2.86K derived: sum of 2 quarters · filed 2015-11-05 | -$23.47K 10-Q · filed 2015-11-05 | -$7.11K derived: sum of 4 quarters · filed 2015-11-05 | |
| 2014-06-30 | -$3.08K 10-Q · filed 2015-08-10 | -$23.69K 10-Q · filed 2015-08-10 | -$7.33K derived: sum of 3 quarters · filed 2015-08-10 | -$116.05K derived: sum of 4 quarters · filed 2015-08-10 | |
| 2014-03-31 | -$20.62K 10-Q · filed 2015-05-11 | -$4.25K derived: sum of 2 quarters · filed 2015-05-11 | -$112.97K derived: sum of 3 quarters · filed 2015-05-11 | -$249.91K derived: sum of 4 quarters · filed 2015-05-11 | |
| 2013-12-31 | $16.37K derived: 10-K 6 month − 10-Q 3 month · filed 2015-03-12 | -$92.35K 10-K · filed 2015-03-12 | -$229.29K derived: sum of 3 quarters · filed 2015-03-12 | -$92.35K 10-K · filed 2016-03-30 | |
| 2013-09-30 | -$108.72K 10-Q · filed 2014-11-10 | -$245.66K derived: sum of 2 quarters · filed 2014-11-10 | -$299.40K 10-Q · filed 2014-11-10 | $11.22K derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-06-30 | -$136.94K 10-Q · filed 2013-08-08 | -$190.68K 10-Q · filed 2013-08-08 | $119.94K derived: sum of 3 quarters · filed 2015-03-12 | -$1.09K derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-03-31 | -$53.74K 10-Q · filed 2013-05-09 | $256.89K derived: sum of 2 quarters · filed 2015-03-12 | $135.86K derived: sum of 3 quarters · filed 2015-03-12 | $67.24K derived: sum of 4 quarters · filed 2015-03-12 | |
| 2012-12-31 | $310.63K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $189.60K derived: sum of 2 quarters · filed 2015-03-12 | $120.98K derived: sum of 3 quarters · filed 2015-03-12 | -$7.58K 10-K · filed 2015-03-12 | -$376.87B 10-K · filed 2013-03-18 |
| 2012-09-30 | -$121.03K 10-Q · filed 2013-11-12 | -$189.65K derived: sum of 2 quarters · filed 2013-11-12 | -$318.21K 10-Q · filed 2013-11-12 | ||
| 2012-06-30 | -$68.62K 10-Q · filed 2013-08-08 | -$197.18K 10-Q · filed 2013-08-08 | |||
| 2012-03-31 | -$128.56K 10-Q · filed 2013-05-09 | ||||
| 2010-12-31 | -$7.09B 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |